Deprenyl as symptomatic therapy in Parkinson's disease.
Golbe
L I
LI
University of Medicine and Dentistry of New Jersey--Robert Wood Johnson Medical School, New Brunswick 08903.
D000978:Antiparkinson Agents / Q000627:therapeutic use; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010627:Phenethylamines / Q000627:therapeutic use*; D012642:Selegiline / Q000009:adverse effects / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D010627:Phenethylamines; D012642:Selegiline